Exhibit 99.1

| • | Revenue of $868 million, a 14% increase compared to the prior quarter and a 19% increase compared to the prior year |
| • | Loss from operations of $21 million; net loss attributable to Tronox of $171 million (including $103 million tax valuation allowance); adjusted net loss attributable to Tronox was $82 million (non-GAAP) |
| • | GAAP diluted loss per share was $1.07; Adjusted diluted loss per share was $0.51 (non-GAAP) |
| • | Adjusted EBITDA of $73 million; Adjusted EBITDA margin of 8.4% (non-GAAP) |
| • | Capital expenditures of $45 million |
| • | Generated free cash flow of $60 million |
| • | Expect to deliver meaningful positive free cash flow for full year 2026, with Q3 relatively neutral |
| • | Expect Q3 2026 TiO2 volumes to be down moderately, in the mid-single-digit percentage range, in-line with normal, seasonal patterns |
| • | Expect Q3 zircon volumes to moderate slightly compared to Q2, due to inventory availability following a very strong first half |
| • | TiO2 pricing expected to improve sequentially in the mid-single-digit percentage range and zircon pricing to improve in the mid- to high single-digit percentage range in Q3 2026 |
| • | Q3 2026 Adjusted EBITDA expected to be $95-$115 million |
| ($M unless otherwise noted) | Q2 2026 | Q2 2025 | Y-o-Y%∆ | | Q1 2026 | Q-o-Q%∆ | | |||||||||||
| Revenue | $ | 868 | $ | 731 | 19 | % | $ | 760 | 14 | % | ||||||||
| TiO2 | $ | 700 | $ | 587 | 19 | % | $ | 616 | 14 | % | ||||||||
| Zircon | $ | 97 | $ | 68 | 43 | % | $ | 89 | 9 | % | ||||||||
| Other products | $ | 71 | $ | 76 | (7 | )% | $ | 55 | 29 | % | ||||||||
| (Loss) from operations | $ | (21 | ) | $ | (35 | ) | n/ | m | $ | (41 | ) | n/ | m | |||||
| Net (loss) attributable to Tronox | $ | (171 | ) | $ | (84 | ) | n/ | m | $ | (103 | ) | n/ | m | |||||
| GAAP diluted (loss) per share | $ | (1.07 | ) | $ | (0.53 | ) | n/ | m | $ | (0.65 | ) | n/ | m | |||||
| Adjusted diluted (loss) per share | $ | (0.51 | ) | $ | (0.28 | ) | n/ | m | $ | (0.55 | ) | n/ | m | |||||
| Adjusted EBITDA | $ | 73 | $ | 93 | (22 | )% | $ | 62 | 18 | % | ||||||||
| Adjusted EBITDA Margin % | 8.4 | % | 12.7 | % | (430) bps | 8.2 | % | 20 bps | ||||||||||
| Free cash flow | $ | 60 | $ | (55 | ) | n/ | m | $ | (135 | ) | n/ | m |
| Y-o-Y % ∆ | Q-o-Q % ∆ | |||||
| Volume | Price / Mix | FX | Volume | Price / Mix | FX | |
| TiO2 | 18 % | 0% | 1% | 9 % | 5 % | 0 % |
| Zircon | 61 % | (18)% | — | 4 % | 5 % | — |
| | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net sales | $ | 868 | $ | 731 | $ | 1,628 | $ | 1,469 | ||||||||
| Cost of goods sold | 813 | 652 | 1,529 | 1,291 | ||||||||||||
| Gross profit | 55 | 79 | 99 | 178 | ||||||||||||
| Restructuring and other charges | 4 | 42 | 18 | 128 | ||||||||||||
| Selling, general and administrative expenses | 72 | 72 | 143 | 146 | ||||||||||||
| Loss from operations | (21 | ) | (35 | ) | (62 | ) | (96 | ) | ||||||||
| Interest expense | (56 | ) | (45 | ) | (109 | ) | (87 | ) | ||||||||
| Interest income | — | 1 | 2 | 3 | ||||||||||||
| Other income (expense), net | 10 | (2 | ) | (2 | ) | (7 | ) | |||||||||
| Loss before income taxes | (67 | ) | (81 | ) | (171 | ) | (187 | ) | ||||||||
| Income tax provision | (106 | ) | (4 | ) | (106 | ) | (9 | ) | ||||||||
| Net loss | (173 | ) | (85 | ) | (277 | ) | (196 | ) | ||||||||
| Net loss attributable to noncontrolling interest | (2 | ) | (1 | ) | (3 | ) | (1 | ) | ||||||||
| Net loss attributable to Tronox Holdings plc | $ | (171 | ) | $ | (84 | ) | $ | (274 | ) | $ | (195 | ) | ||||
| | ||||||||||||||||
| | ||||||||||||||||
| Loss per share: | ||||||||||||||||
| Basic | $ | (1.07 | ) | $ | (0.53 | ) | $ | (1.72 | ) | $ | (1.23 | ) | ||||
| Diluted | $ | (1.07 | ) | $ | (0.53 | ) | $ | (1.72 | ) | $ | (1.23 | ) | ||||
| | ||||||||||||||||
| Weighted average shares outstanding, basic (in thousands) | 159,841 | 158,561 | 159,444 | 158,358 | ||||||||||||
| Weighted average shares outstanding, diluted (in thousands) | 159,841 | 158,561 | 159,444 | 158,358 | ||||||||||||
| | ||||||||||||||||
| Other Operating Data: | ||||||||||||||||
| Capital expenditures | 45 | 83 | 112 | 193 | ||||||||||||
| Depreciation, depletion and amortization expense | 76 | 74 | 151 | 145 | ||||||||||||
| | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| | ||||||||||||||||
| Net loss attributable to Tronox Holdings plc (U.S. GAAP) | $ | (171 | ) | $ | (84 | ) | $ | (274 | ) | $ | (195 | ) | ||||
| Gain on sale of Fuzhou (a) | (20 | ) | — | (20 | ) | — | ||||||||||
| Restructuring and other charges (b) | 4 | 38 | 18 | 124 | ||||||||||||
| Tax valuation allowance (c) | 103 | — | 103 | — | ||||||||||||
| Other (d) | 2 | 1 | 3 | 2 | ||||||||||||
| Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP) | $ | (82 | ) | $ | (45 | ) | $ | (170 | ) | $ | (69 | ) | ||||
| Diluted net loss per share (U.S. GAAP) | $ | (1.07 | ) | $ | (0.53 | ) | $ | (1.72 | ) | $ | (1.23 | ) | ||||
| Gain on sale of Fuzhou, per share | (0.13 | ) | — | (0.13 | ) | — | ||||||||||
| Restructuring and other charges, per share | 0.03 | 0.24 | 0.12 | 0.78 | ||||||||||||
| Tax valuation allowance, per share | 0.65 | — | 0.65 | — | ||||||||||||
| Other, per share | 0.01 | 0.01 | 0.01 | 0.01 | ||||||||||||
| Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1) | $ | (0.51 | ) | $ | (0.28 | ) | $ | (1.07 | ) | $ | (0.44 | ) | ||||
| Weighted average shares outstanding, diluted (in thousands) | 159,841 | 158,561 | 159,444 | 158,358 | ||||||||||||
| | June 30, 2026 | December 31, 2025 | ||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 194 | $ | 199 | ||||
| Restricted cash | 12 | 12 | ||||||
| Accounts receivable (net of allowance for credit losses of $1 and $1 as of June 30, 2026 and December 31, 2025, respectively) | 363 | 289 | ||||||
| Inventories, net | 1,458 | 1,652 | ||||||
| Prepaid and other assets | 113 | 112 | ||||||
| Income taxes receivable | 1 | 1 | ||||||
| Total current assets | 2,141 | 2,265 | ||||||
| Noncurrent Assets | ||||||||
| Property, plant and equipment, net | 1,988 | 2,007 | ||||||
| Mineral leaseholds, net | 595 | 608 | ||||||
| Intangible assets, net | 203 | 214 | ||||||
| Lease right of use assets, net | 180 | 173 | ||||||
| Deferred tax assets | 727 | 833 | ||||||
| Other long-term assets | 116 | 117 | ||||||
| Total assets | $ | 5,950 | $ | 6,217 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current Liabilities | ||||||||
| Accounts payable | $ | 404 | $ | 481 | ||||
| Accrued liabilities | 254 | 274 | ||||||
| Short-term lease liabilities | 24 | 22 | ||||||
| Obligations under inventory financing arrangement | 50 | 50 | ||||||
| Short-term debt | 68 | 51 | ||||||
| Long-term debt due within one year | 39 | 39 | ||||||
| Income taxes payable | 1 | 2 | ||||||
| Total current liabilities | 840 | 919 | ||||||
| Noncurrent Liabilities | ||||||||
| Long-term debt, net | 3,123 | 3,132 | ||||||
| Pension and postretirement healthcare benefits | 80 | 81 | ||||||
| Asset retirement obligations | 209 | 198 | ||||||
| Environmental liabilities | 30 | 39 | ||||||
| Long-term lease liabilities | 156 | 148 | ||||||
| Deferred tax liabilities | 212 | 208 | ||||||
| Other long-term liabilities | 109 | 43 | ||||||
| Total liabilities | 4,759 | 4,768 | ||||||
| Commitments and Contingencies | ||||||||
| Shareholders’ Equity | ||||||||
| Tronox Holdings plc ordinary shares, par value $0.01 — 159,700,029 shares issued and outstanding at June 30, 2026 and 158,557,858 shares issued and outstanding at December 31, 2025 | 2 | 2 | ||||||
| Capital in excess of par value | 2,097 | 2,103 | ||||||
| (Accumulated deficit) retained earnings | (244 | ) | 30 | |||||
| Accumulated other comprehensive loss | (694 | ) | (717 | ) | ||||
| Total Tronox Holdings plc shareholders’ equity | 1,161 | 1,418 | ||||||
| Noncontrolling interest | 30 | 31 | ||||||
| Total equity | 1,191 | 1,449 | ||||||
| Total liabilities and equity | $ | 5,950 | $ | 6,217 | ||||
| | Six Months Ended June 30, | |||||||
| | 2026 | 2025 | ||||||
| Cash Flows from Operating Activities: | ||||||||
| Net loss | $ | (277 | ) | $ | (196 | ) | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
| Depreciation, depletion and amortization | 151 | 145 | ||||||
| Deferred income taxes | 106 | 7 | ||||||
| Share-based compensation expense | 11 | 9 | ||||||
| Amortization of deferred debt issuance costs and discount on debt | 6 | 5 | ||||||
| Restructuring and other charges | 18 | 128 | ||||||
| Other non-cash items affecting net loss | 9 | 29 | ||||||
| Changes in assets and liabilities: | ||||||||
| Increase in accounts receivable, net of allowance for credit losses | (74 | ) | (19 | ) | ||||
| Decrease (increase) in inventories, net | 191 | (76 | ) | |||||
| Decrease in prepaid and other assets | 21 | 29 | ||||||
| Restructuring payments | (29 | ) | (27 | ) | ||||
| Decrease in accounts payable and accrued liabilities | (84 | ) | (23 | ) | ||||
| Net changes in income tax payables and receivables | - | (5 | ) | |||||
| Changes in other non-current assets and liabilities | (12 | ) | (10 | ) | ||||
| Cash provided by (used in) operating activities | 37 | (4 | ) | |||||
| Cash Flows from Investing Activities: | ||||||||
| Capital expenditures | (112 | ) | (193 | ) | ||||
| Loans | - | 15 | ||||||
| Proceeds from dispositions and asset sales | 15 | 2 | ||||||
| Cash used in investing activities | (97 | ) | (176 | ) | ||||
| Cash Flows from Financing Activities: | ||||||||
| Repayments of short-term debt | (99 | ) | (11 | ) | ||||
| Repayments of long-term debt | (16 | ) | (14 | ) | ||||
| Repayments of inventory financing arrangement | (50 | ) | - | |||||
| Proceeds from inventory financing arrangement | 50 | - | ||||||
| Proceeds from sale and leaseback transaction | 75 | - | ||||||
| Proceeds from short-term debt | 116 | 203 | ||||||
| Debt issuance costs | (2 | ) | (1 | ) | ||||
| Sale and leaseback transaction costs | (1 | ) | - | |||||
| Dividends paid | (16 | ) | (20 | ) | ||||
| Restricted stock and performance-based shares settled in cash for withholding taxes | - | (1 | ) | |||||
| Cash provided by financing activities | 57 | 156 | ||||||
| Effects of exchange rate changes on cash and cash equivalents and restricted cash | (2 | ) | 5 | |||||
| Net decrease in cash and cash equivalents and restricted cash | (5 | ) | (19 | ) | ||||
| Cash and cash equivalents and restricted cash at beginning of period | 211 | 152 | ||||||
| Cash and cash equivalents and restricted cash at end of period | $ | 206 | $ | 133 | ||||
| | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
| | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| | ||||||||||||||||
| Net loss (U.S. GAAP) | $ | (173 | ) | $ | (85 | ) | $ | (277 | ) | $ | (196 | ) | ||||
| Interest expense | 56 | 45 | 109 | 87 | ||||||||||||
| Interest income | — | (1 | ) | (2 | ) | (3 | ) | |||||||||
| Income tax provision | 106 | 4 | 106 | 9 | ||||||||||||
| Depreciation, depletion and amortization expense | 76 | 74 | 151 | 145 | ||||||||||||
| EBITDA (non-U.S. GAAP) | 65 | 37 | 87 | 42 | ||||||||||||
| Gain on sale of Fuzhou (a) | (20 | ) | — | (20 | ) | — | ||||||||||
| Share-based compensation (b) | 5 | 4 | 11 | 9 | ||||||||||||
| Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c) | 6 | 7 | 10 | 14 | ||||||||||||
| Accounts receivable securitization program (d) | 4 | 3 | 7 | 7 | ||||||||||||
| Foreign currency remeasurement (e) | 7 | (2 | ) | 14 | (1 | ) | ||||||||||
| Restructuring and other charges (f) | 4 | 42 | 18 | 128 | ||||||||||||
| Other items (g) | 2 | 2 | 8 | 6 | ||||||||||||
| Adjusted EBITDA (non-U.S. GAAP) | $ | 73 | $ | 93 | $ | 135 | $ | 205 | ||||||||
| | Three Months Ended June 30, | |||||||
| | 2026 | 2025 | ||||||
| Net sales | $ | 868 | | $ | 731 | | ||
| Net loss (U.S. GAAP) | $ | (173 | ) | $ | (85 | ) | ||
| Net loss (U.S. GAAP) as a % of Net sales | (19.9 | )% | (11.6 | )% | ||||
| Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales | 8.4 | % | 12.7 | % | ||||
| | | | ||||||
| | June 30, 2026 | December 31, 2025 | ||||||
| Long-term debt, net | $ | 3,123 | | $ | 3,132 | |||
| Short-term debt | 68 | 51 | ||||||
| Long-term debt due within one year | 39 | 39 | ||||||
| (Less) Cash and cash equivalents | (194 | ) | (199 | ) | ||||
| Net debt (1) | $ | 3,036 | $ | 3,023 | | |||
| Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) | $ | 266 | $ | 336 | ||||
| Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above) | 11.4 | x | 9.0 | x | ||||
| | Six Months Ended June 30, 2026 | Three Months Ended March 31, 2026 | Three Months Ended June 30, 2026 | |||||||||
| Cash used in operating activities | $ | 37 | $ | (68 | ) | $ | 105 | |||||
| Capital expenditures | (112 | ) | (67 | ) | (45 | ) | ||||||
| Free cash flow (non-U.S. GAAP) | $ | (75 | ) | $ | (135 | ) | $ | 60 | ||||
| | Three Months Ended | Trailing Twelve Month | ||||||||||||||||||
| | September 30, 2025 | December 31, 2025 | March 31, 2026 | June 30, 2026 | Adjusted EBITDA | |||||||||||||||
| | ||||||||||||||||||||
| Net loss (U.S. GAAP) | $ | (100 | ) | $ | (177 | ) | $ | (104 | ) | $ | (173 | ) | $ | (554 | ) | |||||
| Interest expense | 48 | 54 | 53 | 56 | 211 | |||||||||||||||
| Interest income | (1 | ) | (2 | ) | (2 | ) | — | (5 | ) | |||||||||||
| Income tax provision (benefit) | 8 | (2 | ) | — | 106 | 112 | ||||||||||||||
| Depreciation, depletion and amortization expense | 75 | 82 | 75 | 76 | 308 | |||||||||||||||
| EBITDA (non-U.S. GAAP) | 30 | (45 | ) | 22 | 65 | 72 | ||||||||||||||
| Gain on sale of Fuzhou (a) | — | — | — | (20 | ) | (20 | ) | |||||||||||||
| Share-based compensation (b) | 5 | 6 | 6 | 5 | 22 | |||||||||||||||
| Foreign currency remeasurement (c) | — | 7 | 7 | 7 | 21 | |||||||||||||||
| Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (d) | 6 | (11 | ) | 4 | 6 | 5 | ||||||||||||||
| Accounts receivable securitization program (e) | 3 | 3 | 3 | 4 | 13 | |||||||||||||||
| Restructuring and other charges (f) | 25 | 79 | 14 | 4 | 122 | |||||||||||||||
| Other items (g) | 5 | 18 | 6 | 2 | 31 | |||||||||||||||
| Adjusted EBITDA (non-U.S. GAAP) | $ | 74 | $ | 57 | $ | 62 | $ | 73 | $ | 266 | ||||||||||